Facebook
Twitter
LinkedIn
ForwardNew Opportunities to Identify, Prevent and Manage Fibrosis in Children’s Interstitial and Diffuse Lung Disease 2024
Did you know that only 20% of surveyed physicians identified themselves as confident in most areas of diagnosing, understanding evidence based treatment options and disease mechanisms for pulmonary fibrosis in our pediatric patients? The Childhood ILD (chILD) Network has identified these needs in the medical community and aim to significantly improve these statistics.
chILD is a term used to describe over 200 rare conditions of children with diffuse and interstitial lung disease that can be associated with significant morbidity and mortality. Please join us to participate in a series of conversations on the outcomes of these studies and what the data means for the future of these rare conditions in our pediatric patient populations.
New Opportunities to Identify, Prevent and Manage chILD is an educational event offered throughout 2024. Each session will feature National thought leaders presenting their findings on this new, innovative series of treatments for pediatric fibrosis.
- February 15, 2024 - Los Angeles: Foundations and Frontiers of chILD
- February 29, 2024 - Boston: The Next Generation of chILD
Commercial Support
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals.
On-Demand Learning: Interstitial and Diffuse Lung Disease Online Module
Jump start your education to identify and manage pediatric ILD cases with Children's Hospital Colorado's enduring module, "New Opportunities to Identify, Prevent, and Manage Fibrosis in Children’s Interstitial and Diffuse Lung Disease," available now, free of charge!
Target Audience
This activity is designed for Pediatricians, Internal Medicine-Pediatrics Physicians, Pediatric and Adult Pulmonologists, Rheumatologists, Oncologists, Immunologists, Pediatric Intensivists, Neonatologists, Radiologists, Pathologists, Advanced Practice Providers, Basic and Translational Scientists, and Clinical Research Coordinators.
Learning Objectives
- Explain the conditions associated with childhood interstitial and diffuse lung disease (chILD).
- Review the conditions associated with pulmonary fibrosis in older children.
- List the diagnostic criteria and ongoing longitudinal follow up measurements in older children with pulmonary fibrosis.
- Describe the pathogenesis of pulmonary fibrosis in older children with chILD.
- Identify the interaction needed amongst different health care professionals (pediatricians, different specialists,) with the family and patient.
- Describe the basic pathophysiologic mechanisms in different chILD disorders that may help accelerate therapy
Additional Information
| Boston: The Next Generation of chILD Thursday, February 29, 2024 | |
|---|---|
| 8:00AM | Welcome, Breakfast & Announcements Alicia Casey, MD & Robin Deterding, MD |
| 8:15AM | Vision for the chILD Foundation Katelyn Krivchenia, MD |
| 8:45AM | Visions of the chILD Registry Lisa Young, MD |
| 9:15AM | Multidisciplinary Care of Complex chILD & Show and Tell Alicia Casey, MD, David Hoytema, MD, Benjamin Raby, MD, Aaida Samad, MD, Sara Vargas & Holly Wobma, MD |
| 10:15AM | Q&A |
| 10:30AM | Break |
| 10:45AM | How Can Single Cell and Spatial Studies Inform Future Treatments for Fibrosis? James Hagood, MD |
| 11:15AM | Induced pluripotent stem cells in the pathogenesis of and treatments for ABCA3-associated chILD Erin Hennessy, PhD |
| 11:45AM | chILD Year in Review Elizabeth Fiorino, MD |
| 12:15PM | Q&A |
| 12:30PM | Lunch Break |
| 1:15PM | Multidisciplinary Care and the Role of the Parent Advisory Council Virginia Dimakis, RN, BSN, Jaqueline Steiding, BSN, RN & Lauren Beville |
| 1:45PM | From Patient, To Gene, To Therapy John Kennedy, MD |
| 2:15PM | Transitions From Pediatric to Adult Care for chILD Ahmet Uluer, MD |
| 2:45PM | Major Themes in Early Pulmonary Fibrosis Detection in Adults: What Might be Helpful in Children Matt Hunninghake, MD |
| 3:15PM | Q&A |
| 3:30PM | Break |
| 3:45PM | TBD Darrell Kotton, MD |
| 4:30PM | The Future of chILD Robin Deterding, MD |
| 4:45PM | Q&A |
| 5:00PM - 6:00PM | Conference Adjourn & Reception |
Venue Information
Los Angeles - February 15, 2024
Loews Hollywood Hotel
1755 N Highland Ave
Los Angeles, CA 90028
Boston - February 29, 2024
Convene One Boston Place
201 Washington St
Boston, MA 02108
Travel
Los Angeles - February 15, 2024
For the comfort and convenience of out-of-town learners, we have a limited number of rooms reserved at the Loews Hollywood Hotel. Hotel accommodations are offered at a discounted rate for chILD learners, please mention our event during registration to receive the discount.
To book your stay directly or if you have any questions regarding hotel accommodations, please either contact Lainey Crawford at lainey.crawford@childrenscolorado.org or reach out directly to Loews Hollywood Hotel by calling (323) 856 - 1200.
Boston - February 29, 2024
For the comfort and convenience of out-of-town learners, we have a limited number of rooms reserved at the Omni Parker House Boston. Hotel accommodations are offered at a discounted rate for chILD learners, please mention our event during registration to receive the discount.
To book your stay directly or if you have any questions regarding hotel accommodations, please either contact Jade Freeman at jade.freeman@childrenscolorado.org or reach out directly to Omni Parker House Boston by calling (617) 227-8600.
Los Angeles Faculty Zoha Ahmed, MD Manvi Bansal MD Alicia Casey, MD Michal Cidon, MD Robin Deterding, MD Gail H. Deutsch, MD Freya Shroff, MD Anthony Shum, MD Noa Simchoni, MD, PhD Xin Sun Jennifer Wambach, MD, MS Sally L Davidson Ward, MD Jason Weinman, MD
| Boston Faculty Alicia Casey, MD Robin Deterding, MD Elizabeth Fiorino, MD James Hagood, MD Erin Hennessey John Kennedy Darrell N. Kotton, MD Ahmet Uluer, DO, MPH
|